Skip to main content
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Table 3 MetS components and insulin resistance in both groups

From: Impact of insulin resistance and metabolic syndrome on disability in patients with multiple sclerosis

 

Patient group

(n = 50)

mean ± SD

Control group

(n = 25)

mean ± SD

p value

Systolic blood pressure

121.2 ± 17.5

109.8 ± 13.1

0.005*

Diastolic blood pressure

74.4 ± 14.3

69.4 ± 10.2

0.1

Waist circumference

83.8 ± 14

72.2 ± 8.5

< 0.001*

FBS (mg/dl)

97.6 ± 13.4

85.9 ± 8.2

< 0.001*

Insulin level (mU/L)

16.7 ± 16.7

4.7 ± 1.7

0.001*

HDL (mg/dL)

49.6 ± 6.4

53.8 ± 7.2

0.01*

LDL (mg/dL)

117.3 ± 48.5

79.9 ± 26.6

0.001*

Triglycerides (mg/dL)

103.9 ± 53.2

79.4 ± 20.9

0.02*

HOMA-IR

3.9 ± 3.9

0.99 ± 0.39

< 0.001*

  1. FBS Fasting blood sugar, HDL High-density lipoprotein, LDL Low-density lipoprotein, HOMA-IR The homeostasis model assessment for insulin resistance
  2. *p value < 0.05 is considered statistically significant
Back to article page